
|Articles|June 24, 2004
ASCO submits proposals on CPT code changes for infused drugs
The American Society of Clinical Oncology has submitted a series of proposals to an AMA workgroup aimed at changing a number of CPT codes for infused drugs.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












